Bank Of Nova Scotia Abiomed Inc Transaction History

Bank Of Nova Scotia

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$242.49 - $301.46 $8,972 - $11,154	37 Added 0.98%	3,795 $932,000
Q2 2022 Aug 05, 2022	SELL	$224.73 - $338.64 $420,919 - $634,272	-1,873 Reduced 33.26%	3,758 $930,000
Q1 2022 May 09, 2022	SELL	$277.25 - $366.29 $838,681 - $1.11 Million	-3,025 Reduced 34.95%	5,631 $1.87 Million
Q4 2021 Feb 11, 2022	BUY	$300.63 - $371.35 $376,689 - $465,301	1,253 Added 16.93%	8,656 $3.11 Million
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $209,378 - $253,935	675 Added 10.03%	7,403 $2.41 Million
Q2 2021 Aug 12, 2021	BUY	$262.71 - $351.17 $1.77 Million - $2.36 Million	6,728 New	6,728 $2.1 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.